Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT

Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT

<p>Abstract</p> <p>Background</p> <p>Once-daily (QD) ritonavir 100 mg-boosted fosamprenavir 1400 mg (FPV/r100) or atazanavir 300 mg (ATV/r100), plus tenofovir/emtricitabine (TDF/FTC) 300 mg/200 mg, have not been compared as initial antiretroviral treatment. To address t...

Full description

Bibliographic Details
Main Authors: Ross Lisa L, Liao Qiming, Fischl Margaret A, DeJesus Edwin, Weinberg Winkler G, Smith Kimberly Y, Pakes Gary E, Pappa Keith A, Lancaster C Tracey
Format: Article
Language:English
Published: BMC 2008-03-01
Series:AIDS Research and Therapy
Online Access:http://www.aidsrestherapy.com/content/5/1/5

Similar Items

Similar Items